Since it was firs t d escribed in 1960, a pproximat ely 1000 cases of neurolep tic m ali gn a nt syndrom e (NMS) have been report ed in the lit e ra t ure (1-2). Althou gh the precise pathophysiology is no t well unde rstood , NMS is wid ely recognized as a pot ent iall y fa tal co m plica t ion of treatmen t wit h neu rol e ptic agents. Studies su ggest t hat it is relat ed t o decreased ce n t ra l dop a m in e rgic act ivity , most com monly precipita te d by dop am ine D 2 receptor bloc ka de in the stria tal and hypo tha la m ic sys tems (3) .
Exp e rts have not been a ble to ident ify ac curate ly a subpopu lat ion at inc re ased risk for developin gth e syndrome . H oweve r, a ge ne t ic co mpone nt ofNMS vulne rability has been hypothesiz ed , a nd a rece nt familial case report proposes th at NMS suscept ibility m ay be, in part , a heritabl e cha ract e rist ic (4) . Case reviews su gg est t hat risk fact ors fo r developing NMS in clud e: I) previou s hist ory ofNMS, 2) intramuscul ar delivery a nd / or abr up t inc rease in rat e or tot al dosage of neuroleptic agent, 3) a n tecede n t dop amine a gonist or a n t icholine rg ic m edi ca ti on wit hd rawa l, 4) conc urre n t use of other psych otropi c dru gs, 5) e t ha nol a buse or dep e nde nce, 6) pr e-existing br ain pathology, 7) conc om itan t m edical or n eu rological illn ess, 8) d e hydration, a nd 9) psych omot or ag itat io n (5-7). G ender ra t io of NMS is approximat ely 2: 1 mal e: fem al e, with a n ave rage age of onse t of 38-40. Risk facto rs for NMS a re su m ma rized in T abl e 1.
Diagn osis of NMS re q uires differentiation from clinica lly simi lar synd ro mes including t he se rotoni n syndrome (8) (9) , monamine oxidase in hibitor-induced hyperten sive crisis, m al ign ant hype rth ermi a , heat stroke, a nd let ha l ca ta tonia ( 10-11). Va riou s m edi cal a nd neurological illn esses m ay also resemble NMS , th erefore, di fferential di agn osis of this synd ro me in a me d ica l se tt ing may be problem atic ( 12) . Inv esti gators have ou tline d di agn osti c crite ria to ass ist in dist ingu ishing NMS fr om ot he r clinicall y sim ila r en tities (7, 12) . Th e major crite ria are bas ed on t he presen ce of I ) a u to no m ic instabilit y, 2) ex t ra pyram idal dysfun cti on , 3) hypertherm ia , a nd 4) cloud ed co nsc ious ness. In addition, a variety of a bnormal la bora tory valu es have bee n out line d as mi nor cri teria; I) elevated serum creat ine kina se (C K) activity over 1000 U / liter, 2) white blood ce ll cou nt (WBC) over 15.0 X 10 9 E/lit er, 3) eleva te d liver enzymes, 4) myoglobinuria, 5) elec trolyte ab no rmalities, and 6) diffuse slowing on elec t roe nce phalog ram (13) . Diagn osti c cri teria for NMS a re summarized in T abl es 2 a nd 3.
T reat m en t for NMS includes promp t recogn ition of the syndrom e, imm edi at e ICase # I received a co mbina tion of t rifluperazine 10 mg an d halope ridol 14 mg over a pe riod of48 hours. 2Alt hough co ntrove rs ia l, low se rum iron has been re por ted as a pot enti a l ris k factor for NM S (18) . Abb reviati on s: 1M; intramuscul a r-MR; mental ret arda tion-CS; chronic schizophre nia-OB S; organic brain syndro me.
dis continuation of psychotropic m edi cations, and institution of supportive th erapy. Dopaminergic agonists suc h as bromocriptine, a man tadine , L-dopa , and ca lcium channel blo ck ers, such as dantrolene sod iu m , have d emon st rat ed effectiveness in resolution of th e symptoms, and reduction in associa te d m or t ality ( 14) . A mort al ity rat e of 20-30% sec onda ry to co m plica t ions (pulmonary, ren al , cardiovascu lar) ha s been report ed in untreated cases (15) . W e report three patients wh o pr es ent ed to th e m edi cal service wit h fever, a nd un explain ed e leva te d se r um CK. Following psychi atric co ns u ltation, on e case was di a gn osed with NMS, a nd the possibility of NMS was ruled out in another. Assessment for NMS in th e third pati ent was difficult du e to a com plex medical pr esent ation.
CASE #1
A 5 7-year-old man was tr an sferred from a nursin g hom e to U nive rsity Hospital s of Cl evel and for eva lua t ion and treatm ent of a r ight lowe r ex tre m ity fract ure . T he patient 's past medi cal hist or y was significa nt for gas t roi n tes tina l bleed ing a nd iro n deficie ncy an emia. Hi s psychi a tri c history was rem arkabl e for ment al re tarda t ion secondary to a febri le illn ess a t age four. Befor e ad m ission th e patient had been r eceivin g furosemide 20 mg dai ly, iron sulfa te 300 m g twice dail y. Hi s treat me nt a lso included nortript yline 25 mg twic e dai ly a nd trifluperazin e 2 m g twice daily for psych ological an d behavior al a bno rmalities.
On day three of hospit ali zation , following an ort hopedic procedure, t he patient dem onst ra te d incr ea sin g agi ta t ion, a nd hal op eridol in a dosage of2 mg oral or intramuscu lar eve ry 4 hours as need ed , a nd ben zt ropin e were adde d to his ad m ission med ica tions. Ov er th e next two days, he received a tot al of 14 mg int ramuscul ar halop e rid ol and 2 mg intramuscu lar triflupera zin e in addition to his st anding regim en . Su bse q ue nt ly, t he pati ent developed motor 2Two or mor e of t he following: fluc tuating blood pr essure; ta chycardia; tach ypn ea ; di aphor esis; urinary incontine nce. 3In the abse nce of o ne of th e th r ee major crit eria, pro ba ble d iagnosis is still permitt ed if th e patie nt clearly me e ts t he two remaining major crit eria , and displays one of th e minor crite ria. dysfunction, aspiration pn eumonia , a nd becam e in cr easingly co nfus ed . Antibiot ic the rap y was initiated to treat th e pn eumonia. At psychiatric co nsu ltat ion th e patient was diaphoreti c, wit h a n ora l tem pe rature of 38 .9°C, pul se of 104/min, respirat ion of 321 m in, a nd fluctua tin g blood pressur e betw een 160 / 90 to 108/ 50 mmHg. Mental sta tus exa m ina tion reveal ed co nfus ion, di sor ie ntat ion, and a n inability to co m m un ica te verball y. Neurological exa m ina tion dem on st ra ted marked extrapyr amidal signs, including in cr ea sed muscle ton e, with d iffuse trem or , cogwhee ling, and lead-pipe rigidity in th e upper ex t re m ities. Serum che m ist ries reveal ed a C K level of 1267 U /lit er, le uk ocytosis (15 .0 X 10 9 E/ liter), a nd normal e lec t ro lytes . A tent ative di agn osis of NMS was made. All psychotropic med ications were di scontinued , suppo rt ive t he ra py was initiated, and oral bromocryptine 2.5 mg three times daily was initiated a long with supportive th erapy.
Ov er th e followin g four days th e patient 's ment al sta t us clea red , ex t ra pyra m ida l symptom s resolved, a nd vit al signs sta bilize d (te m pe ra ture 36.6°C, pul se 72/m in , respirat ion 12/min, and blood pr es sure 120/70 mmHg). Laboratory values normal ized , with a C K of 123 U / lit er, and WBC of 7.70 X 10 9 E/lit er. Bromocriptine wa s dis continued , a nd followin g a full course of a nt ibio tic th erapy for pn eumonia the pa ti ent was dis ch arged in improved condition.
CASE # 2
A 72 yea r old man with a pr eadmission di agnosis of ch ro n ic schizo phreni a a nd men ta l ret ardation was ho spitalized for eva lua tion a nd treatm ent of wea kn ess , lethargy, a nd fever of unknown ori gin . His past medi ca l history was significa nt for parkinsoni sm, hyper ten sion, e m physe ma , with ch ronic bronchit is, a nd a hearing deficit. Past su rgica l hist or y includ ed a tr ansurethral prost at ect omy, and cho lecys tectomy . Medi cation s on ad m ission incl ud ed ver a pamil 240 m g d ail y, fluph en a zin e 2.5 mg da ily, ben ztrop ine I mg dail y, a nd ora l a na lges ics.
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Admission findin gs included te mperatu re of 40°C, blood pressure of 118/70 mmHg, pul se 96 / m in, a nd respiration 26/ m in, a mar ked hearing deficit , an d m ild parkinsonism (increased mu scle ton e a nd t rem or). Blood tests were not abl e for WB C of 34.5 X 10 9 E/ lit er, incr eased liver e nzy mes (lac ta te d eh ydrogen ase 27 1 U/liter, a lka line phosphatase 236 U /liter, ga m ma g lu tamyl t ra nsfe rase 307 U / lite r, aspa rta te am ino-tra nsferase 102 U /lit er, a nd a la nine a mi notra nsfe rase 125 U / liter), a nd se rum C K of 4543 U/ lit e r (with negative MB ). Electrocard iogra m did not reveal a ny ischemic changes, a nd se pt ic work-u p (cer ebrospinal fluid , blood a nd uri ne cu lt ures, a nd ches t X-ray) was un reveali ng.
Em piric a nt ibiotic th e rap y for pr esu m ed hepatobil ia ry in fect io n was ini tiated. O ver th e following day, th e patient deferv esced (te m pe ra t ure 36.6°C), with a marked drop in se ru m C K ( 1467 U / lite r) a nd WB C ( 17.4 X 10 9 E/ lite r) . H oweve r, a psychiat ric consultat ion was obtaine d to eva lua te fo r NMS . On mental stat us exa m ina tion, th e pat ient was a lert , o riented, but un abl e to co m m u nica te effec tively because of his hea ri ng deficit. There wa s no evide nce of ac ute beh avior al or psych ological a bno r ma lity. In th e a bse nce of acute psychotic sympt oms, dis continuation of fluph en azine wa s recomm ended . Ov er th e su bseq ue n t four days, th e pati ent cont in ue d to improve, a nd a t th e time of di sch arge from th e hospit al , his se rum CK was 398 U / liter WB C was 7.5 X 10 9 E /lit er, a nd liver e nzymes we re close to norm al.
CASE # 3
A 35-yea r-old man with acq ui re d immunod eficien cy synd rom e (AIDS) d ementia co m plex an d hyp ert en sion en te re d th e hospit al for eva lua tion a nd t rea t men t of new -on set lethargy, wea kness, a nd peripheral neu ropathy. Hi s past psychi atric history was significant for depression a nd one suicide a tte m pt (med ica tio n overdose) . M ed icat ions on admission included flucon a zol e, acyclovi r, tri methoprim , a nd dap son e. G e ne ral ph ysica l and neurologi cal exa mi nation d id not reveal a ny sign ifica nt a bnor malit ies . On mental status exa m ina t ion, he ex hibite d ma rk ed a nxie ty a nd ag ita t ion, with mild cognit ive deficit s (impaired memory and conce nt ration ), but ot herwise he was free of psyc ho tic or dep ressive symptoms. Admission lab oratori es were remarka ble only for a se ru m C K of 634 U '/Iiter, WB C of 2.5 X 10 9 E/liter, a nd lact at e d eh yd ro gen ase of353 U/lite r.
Early in th e course of hospital izat ion , t he patient 's a nxie ty a nd agitation wors en ed, an d he becam e ex t re mely co m ba t ive a nd un coop e rat ive with di agn ost ic pro ced u res. Haloperidol, up to 5 m g d aily, wa s us ed for sedat ion, a nd afte r receiving a tot al of 30 mg over six d ays, his ph ysical a nd mental co nd ition d et eri orat ed markedl y. T empe ratu re increased to 38.0°C , with fluctuat ion s in blood pr essure fro m 110/ 60 mmHg to 120 / 80 mmHg, a nd pulse rat e up to 140/min. The patient a lso d evelop ed lead -p ipe rigidity in th e ex t re m it ies, hype rreflexia , and di aphoresis. Organic workup of his sym pto ms was non cont ributory, with negative blood , urine a nd ce re bro spina l fluid studies. Chest X-ray was norm al, a nd head ma gn eti c resona nce im aging was remarkable onl y for mild a tro phic cha nges .
At psychiatric cons ulta t ion mental st atus exa m ina t ion reveal ed confusion, stu por, a nd impai red speech. Rep eat ed che m ist ries were rem arkabl e for a se ru m C K of 50 1 U / lit er a nd WBC 4. 2 X 10 9 E /lit er. The possibility of NM S wa s rai sed , a nd hal op eridol was discontinu ed, with mod est improvem ent in men tal sta tus, a u to no m ic dysfun ct ion , and ex tra pyra m ida l sym pto ms ove r th e next three days. The pat ient became afebri le wit h a tem perature of36 .5°C , a le r t, a nd was a ble to follow ve rba l co m mands. Tw o days la te r , t he pa tie nt was st art ed on a m pho te r icin B for a presum ed fungal infec tion of t he ce nt ra l ne rvou s system, and a fte r five days ph en othia zin e deri vatives were adde d to his regimen to manage th e gastroint estinal side effects of th e antifungal agent. Subsequently th e patient becam e febril e a nd stu porou s, his motor and autonomic function deteriorated, a nd serum C K incr ea sed to 1161 U / lit er.
Follow-up psychiatric co nsulta t ion, once a gain, suggest ed th e possibil it y of NMS an d re commended abrupt withdrawal of ph enothiazines . D espit e th e di scontinu at ion of th e neuroleptic ag ent , no significant improvem ent follow ed , a nd th e patient was tra nsfer red to the int en sive care unit and subsequently dis charged to a n int ensive nursing ca re facil ity.
DISCUSSION
First described in the lit erature by Delay a nd Denik er ( 16) , as a se rious complication of treatm ent with neurol eptics, NMS is cha racte rized by hype rth er m ia , parkinsonism, and eleva te d serum CK. However, retrospecti ve st udies have dem onstrated that this syndrome is easily confused with other clinical probl e m s in com plicate d medical patients (17) . Our cases illustrate th e difficulties of di agn osin g NMS in patients with concom ita n t medical illn ess.
Diagnosis of NMS in case # I was bas ed on con sid eration of mult ipl e factors. H is risks for dev eloping NMS included receiving intramuscul ar high pot en cy neu roleptic (haloperidol) and increased doses of triftuperazine in th e sett ing of a pre-ex ist ing brain pathology (m ental ret ardation) a nd other conc ur re nt risk fact ors (see T abl e I). Evaluation of his clinical presentation satisfied both Keck and Caroff's di agnost ic criteria of NMS (se e Tables 2 and 3 ). Although fever cou ld have been att ribut ed to th e pn eumonia, th e patient 's m edical cond ition could not ex plain th e seve re parki nsonism and autonomic instability. Marked resolution of th e sym ptom s following abrupt withdrawal of neurol eptics, a nd institution of supportive th erap y a nd t rea tm ent with bromocriptine, furth er supported th e diagnosis of NM S. Fin all y, eleva te d serum CK may have be en secondary to bone fra cture, but th e dram atic drop in C K level following dis continuation of haloperidol and trifluperazin e a lso favored th e diagnosis of NMS. It is of not e that this patient presented with a history of iron deficiency anemia, whi ch has been report ed by som e investigators as a pot en tial risk factor for NMS (18) .
In contrast to patient # I, NMS was rul ed out in patient #2 followin g considera tion of his symptoms, clinical course, and lack of th e signifi cant risk factors (see T abl es 1-3) . The patient had a history of chronic schizophreni a a nd rrient al retard ation, but the absence of any recent cha nge in th e dos e or rout e of ad min istrat ion of fluphenazin e made th e diagnosis of NMS less likely. The mild ext ra pyra m ida l symptoms in this patient, although suggestive of NMS , may hav e been d ue to his pr e-existing parkinsonism. Furthermore, th e course of thi s patient 's illn ess was not typi cal for NMS. Recent studies hav e shown that th e m ean duration ofNMS following appropriate treatment is 6.8 days (19) . Thus, th e rapid resolution of feve r, leukocytosis, and liver enzyme alterations were more likely due to a n tibiotic th erap y for t he pr esum ed biliary tract infection, rather the dis continuation of fluph en azi ne.
The presentation and clinical cou rse of patient # 3 illu strates a d iagnost ic dil emma. Despite this patient 's young ag e, his conc urre n t br ain pathology (AIDSdementia com plex) put him at high risk for NMS wh en ex pose d to high pot e ncy neurol eptics (6) . Hi s clinical course is cons iste n t wit h NMS by both Keck and Caroff's di agn ostic cri teria (see T abl es 2 a nd 3) . Furt hermore, th e remission and rel apse of sym pto ms afte r withd rawal of haloperidol a nd ini ti ation of ph e no t hia zine derivatives resp ecti vely, also favor the di ag nosis ofNMS . H owever , it is difficult to distinguish th e neu rol eptic side effects fro m sym pto ms of AIDS-d em e nti a complex . Human immunodeficien cy viru s (H IV ) in fecti on has been associa te d wi t h subacute e nce pha lit is a nd asep tic m eningi ti s cha racte rize d by men tal confus ion progressing to dem enti a, feve r, m et abolic a bnormalit ies, fat ig ue, a nd movemen t disorde r (20) . Therefore, th e hyp e rthe rmia, mot or dysfuncti on , and al t ered se nsoriu m in t his patient could be a tt ribu te d to HIV e nce phalopa t hy, es pecia lly in t he view of the overall progression of th e sym ptoms eve n afte r th e final withdrawal of pheno thiazine derivatives.
These three cases illu strat e the difficulties tha t clin icians fa ce in acc ura te id entification of NMS in t he me dica lly ill. Carefu l rev iew of the temporal relationships of drug ad mi nist ra t ion a nd th e se q ue nce a nd nature of clinical manifest ation s as th e syndrome evolves, fac ilitate th e diagn osis. Even whe n diagnostic un certainty ex ists, we propose th at in high-risk pati ents, neu rolept ic medications sh ould be wit hhe ld , a nd non-neuroleptic tr eatm ent strategies be considered to co nt ro l th e resid ua l behavior probl ems.
